2021 Corporate Social Responsibility Report

Company: FOSUN PHARMA (2196)
Year: 2021
Published: 2022-04-14
Status: Processed
View Report

Extracted ESG KPIs

KPIs are organized by ESG aspects.

The types of emissions and respective emissions data.

Indicator Unit 2016 2017 2018 2019 2020 2021 2025 2030 Report Pages
Ammonia nitrogen (Fosun Pharma Group) ton/year 60.55 486 254 130 88.5 146 95
Ammonia nitrogen intensity kg/RMB10000 0.0414 0.262 0.102 0.046 0.03 0.038 0.025 0.022 82
COD (Fosun Pharma Group) ton/year 490 841 847 778 655 704 95
COD emission intensity kg/RMB10000 of output value 0.27 0.22 0.18 115
COD emission intensity (Fosun Pharma Group) kg/RMB10000 of output value 0.33 0.45 0.34 0.27 0.22 0.18 95
COD emission intensity (actual in 2021) kg/RMB10000 of output value 0.18 95
COD emissions intensity kg/RMB10000 0.33 0.45 0.34 0.27 0.22 0.18 0.19 0.18 82
Emission of COD tons/year 778 655 704 115
Emission of NH3-N tons/year 130 88 146 115
Emission of nitrogen oxides tons/year 258 158 182 115
Emission of particles tons/year 36 37 25 115
Emission of sulphur oxides tons/year 134 105 101 115
Intensity of nitrogen oxides (g/RMB10000 of output value) g/RMB10000 of output value 46.61 97
Intensity of particles (g/RMB10000 of output value) g/RMB10000 of output value 6.45 97
Intensity of sulfur dioxide (g/RMB10000 of output value) g/RMB10000 of output value 25.91 97
Nitrogen oxides (ton/year) ton/year 466 239 251 258 158 182 97
Non-methane total hydrocarbons (ton/year) ton/year 24.2 42.9 97
Particles (ton/year) ton/year 19 41 44 36 37 25 97
Sulfur oxides (ton/year) ton/year 485 245 279 134 105 101 97
Target VOC emissions control rate 100% 97
Target intensity of nitrogen oxides (g/RMB10000 of output value) g/RMB10000 of output value 49.6 97
Target intensity of particles (g/RMB10000 of output value) g/RMB10000 of output value 11.63 97
Target intensity of sulfur dioxide (g/RMB10000 of output value) g/RMB10000 of output value 33.2 97
VOC emissions control rate 100% 97

Direct (Scope 1) and energy indirect (Scope 2) greenhouse gas emissions (in tonnes) and, where appropriate, intensity (e.g. per unit of production volume, per facility).

Indicator Unit 2016 2017 2018 2019 2020 2021 2025 2030 Report Pages
Ammonia nitrogen emission intensity kg/RMB10000 of output value 0.046 0.03 0.038 115
Ammonia nitrogen emission intensity (Fosun Pharma Group) kg/RMB10000 of output value 0.041 0.262 0.102 0.046 0.03 0.038 95
Ammonia nitrogen emission intensity (actual in 2021) kg/RMB10000 of output value 0.038 95
Carbon emission intensity ton/RMB10000 of output value, tons/RMB10000 of output value, tons/RMB10000 revenue 0.6 0.54 0.41 0.35 0.27 0.23 0.23 0.2 81, 87, 91, 115
Carbon intensity tons/RMB10000 of output value 0.23 91
Direct greenhouse gas emissions ton 288447 338285 397106 381890 225622 308755 91
Indirect greenhouse gas emissions ton 457732 484501 389265 376563 602236 591357 91
Total carbon emission tons/year 758143 827858 900112 115
Total carbon emissions ton 746179 822786 786371 758143 827858 900112 91
Total greenhouse gas emissions from China operations tons 787000 91
Total greenhouse gas emissions from overseas enterprises tons 113000 91

Total hazardous waste produced (in tonnes) and, where appropriate, intensity (e.g. per unit of production volume, per facility).

Indicator Unit 2016 2017 2018 2019 2020 2021 2025 Report Pages
Hazardous waste ton, tons/year 1626.8 2396.9 2688.2 4320.8 5914.5 5953.7 99, 115
Hazardous waste intensity kg/RMB10000 of output value 1.11 1.29 1.07 1.51 1.95 1.53 1.53 81, 99, 115
Solid waste intensity kg/RMB10000 of output value 55.27 48 34.43 25.74 16.26 17.01 23.17 81
Total wastewater tons/year 7091033 6505479 7497581 115
Total wastewater discharge (Fosun Pharma Group) ton/year 6785400 7315890 7565178 7091403 6505479 7497581 95

Total non-hazardous waste produced (in tonnes) and, where appropriate, intensity (e.g. per unit of production volume, per facility).

Indicator Unit 2016 2017 2018 2019 2020 2021 2025 2030 Report Pages
Glass packaging materials consumed ton 5647 11050.5 6299.9 6809.6 101
Recycling rate % 39.4 93
Sewage discharge intensity ton/RMB10000 4.64 3.95 3.04 2.48 2.15 1.92 1.84 1.75 82
Sewage discharge intensity (Fosun Pharma Group) ton/RMB10000 of output value 4.64 3.95 3.04 2.48 2.15 1.92 95
Sewage discharge intensity (actual in 2021) ton/RMB10000 of output value 1.92 95
Sewage discharge intensity (target for 2021) ton/RMB10000 of output value 2.09 95
Total solid waste ton, tons/year 80848 88867 85797 73583.6 49286 66328.4 99, 115
Total solid waste intensity kg/RMB10000 of output value 55.27 48.01 34.36 25.74 16.26 17.01 99, 115
Total solid waste intensity (target) kg/RMB10000 of output value 25.25 99

Description of emissions target(s) set and steps taken to achieve them.

Indicator Unit 2017 2018 2019 2020 2021 2022-2025 Annual average Report Pages
Ammonia nitrogen emission intensity (target for 2021) kg/RMB10000 of output value 0.028 95
COD emission intensity (target for 2021) kg/RMB10000 of output value 0.21 95
Carbon emission reduction from energy-saving projects tons 7900 87
Carbon reduction of energy-saving project ton 7200 5995 4638 7399 7916 6000 81
Recycling amount of socialized resources as percentage of total packaging materials 21.1% 101

Description of how hazardous and non-hazardous wastes are handled, and a description of reduction target(s) set and steps taken to achieve them.

Indicator Unit 2021 Report Pages
Hazardous waste intensity (target) kg/RMB10000 of output value 2.15 99

Direct and/or indirect energy consumption by type (e.g. electricity, gas or oil) in total (kWh in '000s) and intensity (e.g. per unit of production volume, per facility).

Indicator Unit 2016 2017 2018 2019 2020 2021 2025 2030 Report Pages
Comprehensive energy consumption intensity GJ/RMB10000 revenue 2.06 87
Diesel consumption, Healthcare services litre 56383 91
Diesel consumption, Others litre 405437 91
Diesel consumption, Pharmaceutical manufacturing litre 1520474 91
Diesel consumption, Total litre 1982494 91
Direct energy consumption GJ/year 3281502 3389551 4446930 4344819 2604950 3463822 91, 115
Energy consumption intensity GJ/RMB10000 of output value 4.43 3.51 3.11 2.65 2.53 2.06 2.29 2.2 81
Energy consumption other than electricity GJ/year 5304416 115
Fuel oil consumption, Pharmaceutical manufacturing 2870 91
Fuel oil consumption, Total 2870 91
Gasoline consumption, Healthcare services litre 144110 91
Gasoline consumption, Others litre 7804 91
Gasoline consumption, Pharmaceutical manufacturing litre 186215 91
Gasoline consumption, Total litre 409029 91
Indirect energy consumption GJ/year 2304049 2657132 3286332 3231731 5508190 4584921 91, 115
Liquefied gas consumption, Healthcare services kg 3414 91
Liquefied gas consumption, Others kg 6190 91
Liquefied gas consumption, Pharmaceutical manufacturing kg 38976 91
Liquefied gas consumption, Total kg 48580 91
Natural gas consumption, Healthcare services m³ 1277336 91
Natural gas consumption, Others m³ 228537 91
Natural gas consumption, Pharmaceutical manufacturing m³ 19510218 91
Natural gas consumption, Total m³ 21016991 91
Raw coal consumption, Pharmaceutical manufacturing ton 119875 91
Raw coal consumption, Total ton 119875 91
Steam consumption, Pharmaceutical manufacturing ton 582539 91
Steam consumption, Total ton 582539 91
Total electricity consumption kWh/year 478715186 513272112 655108600 631436019 637986028 664674268 91, 115
Total electricity consumption, Healthcare services kWh/year 45740840 91
Total electricity consumption, Others kWh/year 16572325 91
Total electricity consumption, Pharmaceutical manufacturing kWh/year 602369582 91
Total electricity consumption, Total kWh/year 664674628 91
Total energy consumption GJ, GJ/year 5581931 6496683 7753262 7576550 7655768 8048743 91, 115
Total energy consumption intensity GJ/RMB10000 of output value 4.43 3.51 3.11 2.65 2.53 2.06 91
Total energy intensity GJ/RMB10000 of output value 2.65 2.53 2.06 91, 115
Year-on-year increase in total energy consumption GJ 392975 91

Water consumption in total and intensity (e.g. per unit of production volume, per facility).

Indicator Unit 2016 2017 2018 2019 2020 2021 2025 2030 Report Pages
Total amount of recycled and reused water tons 6839912 93
Total water consumption m³/year 8769376 9515697 9959415 9527927 9381818 10521811 93, 115
Total water saving m³ 303088 93
Wastewater discharge intensity tons/RMB10000 of output value 2.48 2.15 1.92 115
Water consumption intensity m³/RMB10000, m³/RMB10000 of output value 5.99 5.14 3.99 3.33 3.1 2.7 2.65 2.39 82, 93, 115
Water consumption intensity (2025 target) m³/RMB10000 of output value 2.65 93

Description of energy use efficiency target(s) set and steps taken to achieve them.

Indicator Unit 2020 Report Pages
Yao Pharma lyophilizer compressor electricity saving kWh 5148.52 40
Yao Pharma lyophilizer electricity saving kWh 27042 40
Yao Pharma lyophilizer vacuum pump electricity saving kWh 8095 40

Description of whether there is any issue in sourcing water that is fit for purpose, water efficiency target(s) set and steps taken to achieve them.

Indicator Unit 2021 Report Pages
Water consumption intensity (target for 2021) m³/RMB10000 of output value 3.01 93
Water-saving projects investment million RMB 1.031 93

Total packaging material used for finished products (in tonnes) and, if applicable, with reference to per unit produced.

Indicator Unit 2018 2019 2020 2021 Report Pages
Metal packaging materials consumed ton 822 352.7 468.4 460.9 101
Packaging materials reused externally and the recycling amount tons 4388 101
Paper packaging materials consumed ton 8341 8550.1 10999.9 9873.4 101
Plastic packaging materials consumed ton 2432 2715.3 1841 3054 101
Rubber packaging materials consumed ton 824 854 468.1 578.1 101
Total consumption of packaging materials tons 20792.5 101
Wood packaging materials consumed ton 180 224 181 16.6 101

Description of the significant impacts of activities on the environment and natural resources and the actions taken to manage them.

Indicator Unit 2019 2020 2021 Report Pages
Investment in environmental protection RMB'0000, million RMB 12483 12078.6 15284.5 8, 115
Number of aseptic production lines certified under EU production lines 2 42
Total environment protection tax paid RMB'000 843.2 85
Total investment in environmental protection facilities RMB'000 13343.2 85

Total workforce by gender, employment type (for example, full- or part-time), age group and geographical region.

Indicator Unit 2019 2020 2021 Report Pages
Disabled employees (number) 72 83 73
Disabled employees (proportion) 0.22% 0.23% 73
Employment rate of ethnic minority employees 3.57% 2.90% 3.08% 114
Employment rate of people with disabilities 0.24% 0.22% 0.23% 114
Female employees (number) 15461 17421 73
Female employees (proportion) 47.93% 48.02% 73
Job vacancies provided globally 36279 7
Labor contract conclusion rate 100% 100% 100% 114
Minority employees (number) 934 1117 73
Minority employees (proportion) 2.90% 3.08% 73
Minority interests RMB'000, RMB100 million 42190 27717 2.52 113
Number of R&D staff 2147 2258 2849 114
Number of employees aged 16–20 51 29 90 66
Number of employees aged 20–30 9975 9828 12157 66
Number of employees aged 30–40 11639 12584 14042 66
Number of employees aged 40–50 6441 6383 6768 66
Number of employees aged 50–55 1894 1953 1848 66
Number of employees aged 55–60 1037 1118 1094 66
Number of employees aged above 60 333 363 280 66
Number of employees in Central China 4081 4718 4891 66
Number of employees in Eastern China 12590 10637 12421 66
Number of employees in Hong Kong, Macao and Taiwan 18 66
Number of employees in Northeast China 1638 2079 2050 66
Number of employees in Northern China 292 1249 1830 66
Number of employees in Northwest China 212 271 66
Number of employees in Southern China 4929 5570 5746 66
Number of employees in Southwest China 2584 2540 2848 66
Number of employees overseas 5256 5253 6204 66
Number of employees with doctor degree 350 411 452 66
Number of employees with junior college degree 8236 8516 9410 66
Number of employees with master degree 3312 3613 4399 66
Number of employees with secondary school and below 9230 8389 8256 66
Number of employees with undergraduate degree 10242 11329 13762 66
Number of ethnic minority employees 1114 934 1117 114
Number of member enterprises 16 93
Number of overseas employees 6204 66
Overseas employees 6204 7
Total employees 32258 36279 73
Total number of employees person 31170 32258 36279 65, 114
Total number of employees by age 31370 32258 36279 66
Total number of employees by education 31370 32258 36279 66
Total number of employees with master and doctor degrees 3662 4024 4851 114
Total number of female employees person 14830 15461 17421 65, 114
Total number of male employees person 16540 16797 18858 65, 114
Total working hours - Healthcare services hours 13945451 75
Total working hours - Medical devices and diagnosis hours 5048472 75
Total working hours - Pharmaceutical manufacturing hours 45789199 75
Total working hours - Total hours 64792222 75
Union coverage rate 100% 100% 100% 114
Year-on-year increase in total number of employees 12.47% 65

Employee turnover rate by gender, age group and geographical region.

Indicator Unit 2019 2020 2021 Report Pages
Operating profit RMB'000, RMB100 million 449356 472115 63.14 113
Ration of female employee returning to work and job positions retained till after the completion of the maternity leave 100% 100% 100% 114
Staff loss rate 16.13% 15.40% 17.14% 73
Staff outflow rate 17.70% 18.76% 21.01% 73

Number and rate of work-related fatalities occurred in each of the past three years including the reporting year.

Indicator Unit 2016 2017 2018 2019 2020 2021 Report Pages
LTI rate - Healthcare services 0.215 75
LTI rate - Pharmaceutical manufacturing 0.175 75
LTI rate - Total 0.17 75
Loss time injury rate per million man-hour 0.58 0.415 0.226 0.343 0.313 0.17 75, 115
Major injury rate per million man-hour 0.22 0.03 0.038 0.08 0.033 75
Minor injury case rate - Healthcare services 0.215 75
Minor injury case rate - Pharmaceutical manufacturing 0.175 75
Minor injury case rate - Total 0.17 75
Minor injury rate per million man-hour 0.36 0.385 0.188 0.343 0.28 0.17 75
Number of Lost Time Injury (LTI) case - Healthcare services 3 75
Number of Lost Time Injury (LTI) case - Pharmaceutical manufacturing 8 75
Number of Lost Time Injury (LTI) case - Total 11 75
Number of Recordable Incident (RI) - Healthcare services 3 75
Number of Recordable Incident (RI) - Pharmaceutical manufacturing 20 75
Number of Recordable Incident (RI) - Total 23 75
Occupational hazard exposure rate 12.66% 12.33% 115
Occupational hazard factor exposure percentage (Healthcare services) % 5.02 78
Occupational hazard factor exposure percentage (Medical devices and diagnosis) % 8.14 78
Occupational hazard factor exposure percentage (Pharmaceutical manufacturing) % 19.12 78
Occupational hazard factor exposure percentage (Total) % 15.16 78
RI rate - Healthcare services 0.215 75
RI rate - Pharmaceutical manufacturing 0.437 75
RI rate - Total 0.355 75
Recordable incident rate 0.355 75
Recordable incident rate per million man-hour 1.05 0.915 0.433 0.395 0.494 0.355 75
Recordable injury rate per million man-hour 0.395 0.494 0.355 115

Lost days due to work injury.

Indicator Unit 2021 Report Pages
Lost time - Healthcare services 60 75
Lost time - Pharmaceutical manufacturing 222 75
Lost time - Total 282 75
Lost time injury rate 0.17 75
Lost time injury rate decrease compared to 2020 % -45.8 75

Description of occupational health and safety measures adopted, and how they are implemented and monitored.

Indicator Unit 2019 2020 2021 Report Pages
Completion rate of occupational health examination (Healthcare services) % 100 78
Completion rate of occupational health examination (Medical devices and diagnosis) % 100 78
Completion rate of occupational health examination (Pharmaceutical manufacturing) % 99.9 78
Completion rate of occupational health examination (Total) % 99.9 78
Investment in health and safety RMB'0000 5801 6186 8192 115
Number of employees exposed to occupational hazards (Healthcare services) employees 302 78
Number of employees exposed to occupational hazards (Medical devices and diagnosis) employees 195 78
Number of employees exposed to occupational hazards (Pharmaceutical manufacturing) employees 3750 78
Number of employees exposed to occupational hazards (Total) employees 4247 78
Total EHS training hours hours 404227 434130 391582 115
Total investment in occupational health and safety RMB'000 8811.92 85

The percentage of employees trained by gender and employee category (e.g. senior management, middle management).

Indicator Unit 2019 2020 2021 Report Pages
Cultivated people with black belt (as of the end of 2021) 16 7
Cultivated people with green belt 364 7
R&D Expenditure (including capitalized investment expense) RMB100 million 34.63 40.03 49.75 34
R&D Expenditure of pharmaceutical manufacturing segment RMB billion 8.486 34
R&D expenditure (including capitalized expenditures) RMB million 4975 7
R&D expenditure (including capitalized investment expenses) RMB100 million 34.63 40.03 49.75 114
R&D expenditure year-on-year growth 24.28% 7
R&D expense RMB100 million 20.41 27.95 38.34 34
R&D expense as percentage of revenue of pharmaceutical segment 11.62% 34
R&D expense of pharmaceutical manufacturing segment RMB billion 3.359 34
Training for Senior Management (Number of trainees) Person 1193 482 258 68
Training for Senior Management (Total training time) Hour 33356 20712 14016 68
Training for employees other than senior management (Number of trainees) Person 30012 30260 27982 68
Training for employees other than senior management (Total training time) Hour 960008 646849 656078 68

The average training hours completed per employee by gender and employee category.

Indicator Unit 2019 2020 2021 Report Pages
Average Training Hours Per Person (All employees) hours/person 31 21 19 68
Average Training Hours Per Person (Female employees) hours/person 28 20 19 68
Average Training Hours Per Person (Male employees) hours/person 34 21 20 68
EHS training hours per employee hours 14.65 14.99 13.97 115
EHS training times per employee times 2.5 5.47 7.57 115
Total Training Expenses RMB'000 1480 904 837 68
Total training hours man-hour 993364 667561 670094 114

Number of suppliers by geographical region.

Indicator Unit 2021 Report Pages
Number of suppliers Overseas 315 60
Number of suppliers in Anhui 63 60
Number of suppliers in Beijing 68 60
Number of suppliers in Chongqing 118 60
Number of suppliers in Fujian 16 60
Number of suppliers in Gansu 9 60
Number of suppliers in Guangdong 88 60
Number of suppliers in Guangxi 71 60
Number of suppliers in Guizhou 2 60
Number of suppliers in Hainan 14 60
Number of suppliers in Hebei 155 60
Number of suppliers in Heilongjiang 26 60
Number of suppliers in Henan 47 60
Number of suppliers in Hong Kong, Macau, Taiwan 9 60
Number of suppliers in Hubei 69 60
Number of suppliers in Hunan 71 60
Number of suppliers in Inner Mongolia 13 60
Number of suppliers in Jiangsu 563 60
Number of suppliers in Jiangxi 47 60
Number of suppliers in Jilin 32 60
Number of suppliers in Liaoning 110 60
Number of suppliers in Ningxia 4 60
Number of suppliers in Qinghai 3 60
Number of suppliers in Shaanxi 19 60
Number of suppliers in Shandong 269 60
Number of suppliers in Shanghai 335 60
Number of suppliers in Shanxi 23 60
Number of suppliers in Sichuan 103 60
Number of suppliers in Tianjin 50 60
Number of suppliers in Tibet 2 60
Number of suppliers in Xinjiang 12 60
Number of suppliers in Yunnan 5 60
Number of suppliers in Zhejiang 186 60
Number of suppliers involved in business for the year - Aleph 25 60
Number of suppliers involved in business for the year - Aohong Pharma 62 60
Number of suppliers involved in business for the year - Eye Pharma 177 60
Number of suppliers involved in business for the year - Guilin Pharma 137 60
Number of suppliers involved in business for the year - Hongqi Pharma 75 60
Number of suppliers involved in business for the year - Shanghai Henlius 140 60
Number of suppliers involved in business for the year - Wanbang Pharma 780 60
Number of suppliers involved in business for the year - Yao Pharma 578 60

Description of practices relating to engaging suppliers, number of suppliers where the practices are being implemented, and how they are implemented and monitored.

Indicator Unit 2021 Report Pages
Number of suppliers under annual review - Aleph 25 60
Number of suppliers under annual review - Aohong Pharma 62 60
Number of suppliers under annual review - Eye Pharma 149 60
Number of suppliers under annual review - Guilin Pharma 137 60
Number of suppliers under annual review - Hongqi Pharma 75 60
Number of suppliers under annual review - Shanghai Henlius 140 60
Number of suppliers under annual review - Wanbang Pharma 670 60
Number of suppliers under annual review - Yao Pharma 400 60
Number of suppliers under annual review / Number of suppliers involved in business for the year - Aleph 100.0% 60
Number of suppliers under annual review / Number of suppliers involved in business for the year - Aohong Pharma 100.0% 60
Number of suppliers under annual review / Number of suppliers involved in business for the year - Eye Pharma 84.2% 60
Number of suppliers under annual review / Number of suppliers involved in business for the year - Guilin Pharma 100.0% 60
Number of suppliers under annual review / Number of suppliers involved in business for the year - Hongqi Pharma 100.0% 60
Number of suppliers under annual review / Number of suppliers involved in business for the year - Shanghai Henlius 100.0% 60
Number of suppliers under annual review / Number of suppliers involved in business for the year - Wanbang Pharma 86.1% 60
Number of suppliers under annual review / Number of suppliers involved in business for the year - Yao Pharma 69.2% 60

Number of products and service related complaints received and how they are dealt with.

Indicator Unit 2019 2020 2021 Report Pages
Annual earnings from Fosun Pharma FOPEX approximately RMB million 100 7
Net asset value per share attributable to shareholders of listed companies (RMB/share) RMB/share 12.44 14.44 15.29 113
Revenue from healthcare services segment RMB100 million 30.4 31.72 41.18 11
Revenue from medical devices and medical diagnosis segment RMB100 million 37.36 52.17 59.38 11
Revenue from pharmaceutical manufacturing segment RMB100 million 217.66 218.8 289.04 11
Revenue year-on-year growth 28.70% 7

Description of practices relating to observing and protecting intellectual property rights.

Indicator Unit 2019 2020 2021 Report Pages
Number of enterprises passed ISO 13485:2016 certification (medical devices and diagnosis subsidiaries) enterprises 8 42
Number of patent application 136 176 186 114
Number of patents granted 47 70 62 114
Number of sterile preparation production lines certified under China GMP production lines 38 42
Number of sterile preparation production lines certified under US FDA production line 1 42
Pipeline projects by end of year 240 7

Description of quality assurance process and recall procedures.

Indicator Unit 2021 Report Pages
Number of APIs certified under China GMP APIs 87 42
Number of APIs certified under EU APIs 3 42
Number of APIs certified under Japan PMDA APIs 4 42
Number of APIs certified under US FDA APIs 13 42
Number of APIs certified under WHO APIs 4 42
Number of enterprises passed CE product certification (medical devices and diagnosis subsidiaries) enterprises 5 42
Number of enterprises passed ISO9001:2015 certification (medical devices and diagnosis subsidiaries) enterprises 3 42
Number of injection production lines certified under WHO production lines 4 42
Number of oral dosage production lines certified under China GMP production lines 40 42
Number of oral solid formation production lines certified under US FDA production lines 2 42
Number of oral solid formation production lines certified under WHO production line 1 42

Number of concluded legal cases regarding corrupt practices brought against the issuer or its employees during the reporting period and the outcomes of the cases.

Indicator Unit 2019 2020 2021 Report Pages
Less: income tax RMB'000, RMB100 million 78223 73786 10.66 113
Less: non-operating expenses RMB'000, RMB100 million 4518 6639 2.89 113
The weighted average return on equity after non-recurring gain or loss (%) % 7.77 8.04 8.58 113
Under investigation items items 264 247 over 240 114

Focus areas of contribution (e.g. education, environmental concerns, labour needs, health, culture, sport).

Indicator Unit 2019 2020 2021 Report Pages
Basic earnings per share (RMB/share) RMB/share 1.3 1.43 1.85 113
Basic earnings per share after non-recurring gain or loss (RMB/share) RMB/share 0.87 1.06 1.28 113
Tax liability RMB'000, RMB100 million 253227 248578 22.71 113
Tax payment RMB million, RMB100 million 25.33 24.86 2271 7, 11

Resources contributed (e.g. money or time) to the focus area.

Indicator Unit 2019 2020 2021 Report Pages
Add: non-operating income RMB'000, RMB100 million 7737 2308 0.29 113
Donations RMB'000, RMB100 million 1504 4038 0.36 113
Investment income RMB'000, RMB100 million 356550 228398 46.24 113
Other income RMB'000, RMB100 million 31305 39363 3.28 113
Revenue RMB million, RMB'000, RMB100 million 2585515 303.07 390.05 7, 11, 113
Social contribution per share RMB 4.59 4.83 5.85 114
Social contribution value per share RMB 5.85 7
Total donation to society million RMB 36.06 8

The types of emissions and respective emissions data.

Standard Indicator Unit 2016 2017 2018 2019 2020 2021
Airborne Particulate Matter (PM) Emissions ton/year 19 41 44 36 37 25
NOâ‚“ Emission Intensity (By Revenue) g/RMB10000 of output value 46.61
NOâ‚“ Emissions ton/year 466 239 251 258 158 182
PM Emission Intensity (By Revenue) g/RMB10000 of output value 6.45
SOâ‚“ Emission Intensity (By Revenue) g/RMB10000 of output value 25.91
SOâ‚“ Emissions ton/year 485 245 279 134 105 101

Direct (Scope 1) and energy indirect (Scope 2) greenhouse gas emissions (in tonnes) and, where appropriate, intensity (e.g. per unit of production volume, per facility).

Standard Indicator Unit 2016 2017 2018 2019 2020 2021 2025 2030
Direct GHG Emissions (Scope 1) ton 288447 338285 397106 381890 225622 308755
Indirect Energy Emissions (Scope 2) ton 457732 484501 389265 376563 602236 591357
Total GHG Emissions ton 746179 822786 786371 758143 827858 900112
Total GHG Emissions Intensity (By Revenue) ton/RMB10000 of output value 0.6 0.54 0.41 0.35 0.27 0.23 0.23 0.2

Total hazardous waste produced (in tonnes) and, where appropriate, intensity (e.g. per unit of production volume, per facility).

Standard Indicator Unit 2016 2017 2018 2019 2020 2021 2025
Total Hazardous Waste ton 1626.8 2396.9 2688.2 4320.8 5914.5 5953.7
Total Hazardous Waste Intensity (By Revenue) kg/RMB10000 of output value 1.11 1.29 1.07 1.51 1.95 1.53 1.53

Total non-hazardous waste produced (in tonnes) and, where appropriate, intensity (e.g. per unit of production volume, per facility).

Standard Indicator Unit 2016 2017 2018 2019 2020 2021
Glass Waste ton 5647 11050.5 6299.9 6809.6
Non-Hazardous Waste (Domestic Waste) ton
Non-Hazardous Waste Disposed ton
Recycling Rate of Non-Hazardous Waste % 39.4
Total Non-Hazardous Waste Intensity (By Revenue) kg/RMB10000 55.27 48.01 34.36 25.74 16.26 17.01

Description of emissions target(s) set and steps taken to achieve them.

Standard Indicator Unit 2017 2018 2019 2020 2021
CO2 Emissions Reduction Compared to Last Year ton 7200 5995 4638 7399 7916

Description of how hazardous and non-hazardous wastes are handled, and a description of reduction target(s) set and steps taken to achieve them.

Standard Indicator Unit 2021
Target Hazardous Waste Intensity Reduction Percentage Compared to Last Year kg/RMB10000 of output value 2.15

Direct and/or indirect energy consumption by type (e.g. electricity, gas or oil) in total (kWh in '000s) and intensity (e.g. per unit of production volume, per facility).

Standard Indicator Unit 2016 2017 2018 2019 2020 2021 2025 2030
Diesel Fuel Consumption litre 1982494
Energy Consumption Intensity (By Revenue) GJ/RMB10000 of output value 4.43 3.51 3.11 2.65 2.53 2.06 2.29 2.2
Fossil Fuel Consumption ton 119875
Gasoline Consumption litre 409029
LPG Consumption kg 48580
Natural Gas Consumption m³ 21016991
Purchased Electricity kWh/year 478715186 513272112 655108600 631436019 637986028 664674628
Purchased Steam ton 582539
Renewable Energy Consumption kWh
Solar Energy kilowatt-hours 80000
Total Direct Energy Consumption GJ/year 3281502 3389551 4446930 4344819 2604950 3463822
Total Energy Consumption GJ/year 5581931 6496683 7753262 7576550 7655768 8048743
Total Indirect Energy Consumption GJ/year 2304049 2657132 3286332 3231731 5508819 4584921

Water consumption in total and intensity (e.g. per unit of production volume, per facility).

Standard Indicator Unit 2016 2017 2018 2019 2020 2021 2025 2030
Recycled Water Usage tons 6839912
Wastewater Discharge Intensity tons/RMB10000 of output value 2.48 2.15 1.92
Water Consumption m³/year 8769376 9515697 9959415 9527927 9381818 10521811
Water Consumption Intensity (By Revenue) m³/RMB10000 5.99 5.14 3.99 3.33 3.1 2.7 2.65 2.39

Description of energy use efficiency target(s) set and steps taken to achieve them.

Standard Indicator Unit 2020
Electricity Usage Reduction Compared to Last Year kWh 27042
Investment in Energy-saving and Emission-reduction Technology Transformation RMB'000

Description of whether there is any issue in sourcing water that is fit for purpose, water efficiency target(s) set and steps taken to achieve them.

Standard Indicator Unit 2021
Target Water Consumption Reduction Percentage Compared to Last Year m³/RMB10000 of output value 3.01

Total packaging material used for finished products (in tonnes) and, if applicable, with reference to per unit produced.

Standard Indicator Unit 2018 2019 2020 2021
Packaging Material Consumption (Metal) ton 822 352.7 468.4 460.9
Packaging Material Consumption (Paper) ton 8341 8550.1 10999.9 9873.4
Packaging Material Consumption (Plastic) ton 2432 2715.3 1841 3054
Packaging Material Consumption (Rubber) ton 824 854 468.1 578.1
Packaging Materials Consumed tons 12699 12696.1 13958.4 20792.5
Packaging Materials Waste Recycled tons 4388
Usage of Packaging Materials (Wood) ton 180 224 181 16.6

Total workforce by gender, employment type (for example, full- or part-time), age group and geographical region.

Standard Indicator Unit 2019 2020 2021
Number of Bachelor's Degree Employees 10242 11329 13762
Number of Below Junior College Employees 9230 8389 8256
Number of Doctoral Degree Employees 350 411 452
Number of Employees Aged 30-50 18080 18967 20810
Number of Employees Aged Above 50 3264 3434 3222
Number of Employees Aged Below 30 10026 9857 12247
Number of Employees in Central China 4081 4718 4891
Number of Employees in East China 12590 10637 12421
Number of Employees in Hong Kong 18
Number of Employees in North China 292 1249 1830
Number of Employees in Northeast China 1638 2079 2050
Number of Employees in Northwest China 212 271
Number of Employees in Overseas 5256 5253 6204
Number of Employees in South China 4929 5570 5746
Number of Employees in Southwest China 2584 2540 2848
Number of Female Employees person 14630 15461 17421
Number of Male Employees person 16540 16797 18858
Number of Master's Degree Employees 3312 3613 4399
Number of Total Employees person 31370 32258 36279
Percentage of Female Employees % 47.93 48.02

Employee turnover rate by gender, age group and geographical region.

Standard Indicator Unit 2019 2020 2021
Percentage of Employees still Employed 12 Months after Return to Work (Female) % 100 100 100
Turnover Rate of Total Employees % 16.13 15.4 17.14

Lost days due to work injury.

Standard Indicator Unit 2021
Lost Days Due to Work-related Injuries 282
Lost Time Injury Frequency Rate (LTIFR/LTIR) 0.17

Description of occupational health and safety measures adopted, and how they are implemented and monitored.

Standard Indicator Unit 2019 2020 2021
Health Check Coverage for Employees % 99.9
Investment in Work Safety RMB'0000 5801 6186 8192
Total Hours of Safety Training for Employees hours 404227 434130 391582

The percentage of employees trained by gender and employee category (e.g. senior management, middle management).

Standard Indicator Unit 2019 2020 2021
Percentage of Trained General Employees % 96.18 98.43 99.08
Percentage of Trained Senior Management % 3.82 1.57 0.92

The average training hours completed per employee by gender and employee category.

Standard Indicator Unit 2019 2020 2021
Average Training Hours (Female) hours/person 28 20 19
Average Training Hours (Male) hours/person 34 21 20
Average Training Hours per Employee hours/person 31 21 19
Total Training Hours man-hour 993364 667561 670094
Training Hours of ESG hours/person 14.65 14.99 13.97

Number of suppliers by geographical region.

Standard Indicator Unit 2021
Number of Suppliers in Hong Kong 9
Number of Suppliers in Mainland China 2837
Number of Suppliers in Overseas 315
Number of Total Suppliers 3152

Description of practices relating to observing and protecting intellectual property rights.

Standard Indicator Unit 2019 2020 2021
Number of Patents Applied 136 176 186
Number of Patents Granted 47 70 62

Number of concluded legal cases regarding corrupt practices brought against the issuer or its employees during the reporting period and the outcomes of the cases.

Standard Indicator Unit 2019 2020 2021
Number of Confirmed Incidents of Corruption items 264 247 over 240

Resources contributed (e.g. money or time) to the focus area.

Standard Indicator Unit 2019 2020 2021
Total Public Welfare Donations RMB'000 1504 4038 36.06
Total Social Investment RMB'000 31305 2308 3.28